Viewing StudyNCT00227721



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00227721
Status: COMPLETED
Last Update Posted: 2020-12-02
First Post: 2005-09-26

Brief Title: Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
Sponsor: Robert Morris
Organization: Barbara Ann Karmanos Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-02
Start Date Type: None
Primary Completion Date: 2011-06
Primary Completion Date Type: ACTUAL
Completion Date: 2017-02
Completion Date Type: ACTUAL
First Submit Date: 2005-09-26
First Submit QC Date: September 26 2005
Study First Post Date: 2005-09-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-02-09
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-30
Last Update Post Date: 2020-12-02
Last Update Post Date Type: ACTUAL